Mr Sergei Makhenzon, OT | |
1469 Appling Dr, Mt Pleasant, SC 29464-4688 | |
(843) 225-4519 | |
Not Available |
Full Name | Mr Sergei Makhenzon |
---|---|
Gender | Male |
Speciality | Occupational Therapist |
Location | 1469 Appling Dr, Mt Pleasant, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013310416 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 3200 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Sergei Makhenzon, OT 3203 Rose Walk Ct, Mt Pleasant, SC 29466-8511 Ph: (843) 513-4139 | Mr Sergei Makhenzon, OT 1469 Appling Dr, Mt Pleasant, SC 29464-4688 Ph: (843) 225-4519 |
News Archive
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance on monoclonal antibody ICT-69 which targets multiple myeloma and ovarian cancers. The antibody has demonstrated high specificity to these cancers by targeting a novel cell surface antigen.
Vertex Pharmaceuticals Incorporated today announced interim results from the first part of a Phase 2 study designed to evaluate multiple combination regimens of VX-770 and VX-809, Vertex's lead medicines in development that aim to treat the defective protein that causes cystic fibrosis.
Around 1 in 6 older people experience some form of abuse, a figure higher than previously estimated and predicted to rise as populations age worldwide.
Santalis Pharmaceuticals Inc., a joint venture with TFS Corporation Ltd., of Australia (ASX: TFC) is pleased to report the execution of an exclusive license agreement with a global pharmaceutical company for the marketing of a number of over-the-counter (OTC) dermatology products containing TFS' sustainably cultivated, pharmaceutical-grade East Indian Sandalwood Oil (EISO).
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 1 days ago
Lauren Webb, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1127 Queensborough Blvd Ste 104, Mt Pleasant, SC 29464 Phone: 843-216-0290 | |
Miss Rachel Helen Cousar, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1127 Queensborough Blvd Ste 104, Mt Pleasant, SC 29464 Phone: 404-771-2468 | |
Ms. Wendy Ball Free, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1308 Pilsdon Crst, Mt Pleasant, SC 29464 Phone: 843-323-2103 | |
Kayla Soltis, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 85c Vincent Dr, Mt Pleasant, SC 29464 Phone: 843-822-2292 | |
Mrs. Christine Roebuck Blake, OTR L CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 570 Long Point Rd, Suite 270, Mt Pleasant, SC 29464 Phone: 843-884-4783 Fax: 843-884-1979 | |
Anna Blair Henderson, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1351 Fairmont Ave, Mt Pleasant, SC 29464 Phone: 704-534-4471 |